Earnings digests and industry comparisons for Japan's biggest listed companies.
237 reports(page 14 of 20)

Alps Alpine announced plans to sell its entire stake in Nippon Seiki, recognizing an extraordinary gain of approximately 5 billion yen. This move materializes concrete results from its policy holding reduction aimed at improving capital efficiency.

Toho announced a mid-term dividend of 11 yen per share for the August 2026 term. This figure reflects a 5-for-1 stock split and represents a real increase from the adjusted prior-year level.

Toho will report a 10 billion yen special profit by selling listed stocks in September 2026. The move aligns with its policy to reduce cross-shareholdings and lower its net asset ratio.

Shin-Etsu will issue a special dividend of 20 yen per share to mark its centenary in September 2026. This move raises the full-year payout forecast for the March 2027 term by approximately 28% year-on-year.

Takara Holdings disclosed a plan on Sept. 15 to divest 18 rental properties, aiming to record an approximately 8.8 billion yen special gain by fiscal year 2027. This move supports the company's strategic push to enhance capital efficiency and achieve its mid-term ROIC targets.

JACCS announced a capital alliance with Solvvy on Sept. 15, 2026. The deal involves acquiring shares for about 6 billion yen to co-create a DX platform.

Taisei announced on September 14 that its final conviction for antitrust violations regarding Chuo Shinkansen construction is confirmed after the Supreme Court rejected its appeal. The company will pay a fine of 250 million yen as legal proceedings conclude with no further remedies available.

Kajima has received a Tokyo District Court decision to start civil rehabilitation proceedings, addressing liabilities totaling 1.3 trillion yen. The company suspended stock trading immediately to stabilize operations.

Otsuka reported that its subunit Daio has achieved a significant progression-free survival extension in treating advanced non-small cell lung cancer. The phase 3 trial showed hazard ratios of 0.50, highlighting the potential for a new treatment standard.

Hanwa will cancel 10.33 million treasury shares, reducing its total issued shares by 4.9 percent. This capital policy aims to boost earnings per share and enhance shareholder value through significant equity reduction.

Chubu Electric will withdraw its license application for the Hamadora nuclear units, citing critical doubts regarding data reliability. This decision halts the re-examination process pending trust restoration.

Chubu Electric disclosed a report confirming it provided false explanations regarding seismic motion calculations for the Hamamoto nuclear plant. This revelation of fraudulent conduct during regulatory reviews significantly delays the path to reactor restart.